Admetsys Secures CE Mark Approval For PrecisionOne™ Automated Glycemic Control And Continuous Diagnostics System
The PrecisionOne system functions as a metabolic autopilot, providing automated glucose regulation and real-time analysis of blood chemistry values for critical care patients.
Read More →
Admetsys is accepted into the Second TiE ScaleUp Cohort
This year’s TiE ScaleUp Cohort includes the following companies, several of them being alums of MassChallenge, TechStars, Harvard i-Lab and Learn Launch: Admetsys, Advanced Continuing Education Association, Avrio, Blackburn Energy, Cintell, Entromy, HelloToken, KnipBio, Nested Bean, Neumitra, Renew Energy Partners, Rifiniti, Shearwater and Wizdy.
Admetsys is accepted into the Dreamit Health 2016 accelerator class
Admetsys has developed an artificial pancreas device that measures, models, and treats patients at diabetic risk. Admetsys is one of the 15 health startups that will join the next Dreamit Health accelerator class.
Admetsys Awarded Top Company at the 2015 Digital European Venture Summit
Admetsys has been awarded Top Company by Tech Tour and the European Venture Contest at the 2015 Digital Health Venture Forum and has been nominated to present its Smart Pancreas™ technology for hospitalized diabetics at the 2015 European Venture Summit in Düsseldorf, Germany.
Admetsys wins Worcester’s Five Minute Pitch Contest
Boston-based Admetsys was the winner of The Venture Forum's ninth annual Five-Minute-Pitch contest, held in Worcester Tuesday. Admetsys CEO Jeff Valk gave the winning presentation, earning the $2,500 first prize and the $1,000 audience choice award.
Admetsys Wins Top Prize at SXSW Hatch Pitch competition
At the Hatch pitch competition five companies came away victorious including Admetsys. The winners received first round interview at Entrepreneurs Roundtable Accelerator; slots in two other accelerators; credits for services from Microsoft and Amazon; entrepreneur office hours.